Healthcare | Financial Buzz

Tag: Healthcare

post-image
Breaking News Buzz On The Street Healthcare Market News Medical Use Pharmaceutical Products Recreational Use Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: HempFusion (OTCQX: CBDHF) (TSX: CBD.U) CBD Clinical Trial at Mount Sinai

Author financial buzzPosted on
1694
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New...
post-image
Breaking News Cannabis Buzz Healthcare Investing News Market News Medical Use Pharmaceutical Products Recreational Use The Market Buzz

Breaking News: HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York

Author financial buzzPosted on
4943
HempFusion Wellness Inc. (OTCQX: CBDHF) (TSX: CBD.U) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to...
post-image
Breaking News Buzz On The Street Cleantech Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: NEXE Innovations (OTC: NEXNF) (TSX-V: NEXE) to Develop Facemasks

Author financial buzzPosted on
1546
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “NEXE Developing Compostable Single-Use Facemasks” NEXE Innovations Inc. (OTC: NEXNF) (TSX-V: NEXE) (“NEXE” or the “Company”), a...
post-image
Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring Study

Author financial buzzPosted on
1645
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study...
post-image
Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Author financial buzzPosted on
3639
Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE: AGN) (FRANKFURT: AGW) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has decided to review...